Pfizer’s Acquisition of Metsera: What It Means for the Future of Obesity Drug Investments
Pfizer agreed to acquire obesity drug developer Metsera for up to $86.25 per share, winning a bidding war against Novo
Read More
Pfizer agreed to acquire obesity drug developer Metsera for up to $86.25 per share, winning a bidding war against Novo
Read More
The Ministry of Commerce, Industry and Investment Promotion (MoCIIP) in Oman runs the “Outstanding Companies” initiative, celebrating private enterprises excelling
Read More
Oman is enhancing its digital economy through the National Digital Economy Programme, targeting a 10% GDP contribution by 2040. With
Read More
The Al Mazunah Free Zone has attracted over RO 140 million in investments by October 2025, with 13 new projects
Read More
The Duqm Refinery in Oman exemplifies sustainable industrial transformation, enhancing production capacity and environmental stewardship. Operating at full capacity since
Read More
Visit Oman, part of OMRAN Group, has partnered with Bókun, a Tripadvisor company, to enhance Oman's tourism offerings. This collaboration
Read More
Oxy Oman’s pilot CO₂ enhanced oil recovery (EOR) project in Block 9 aims to boost oil recovery and support Oman’s
Read More
The Muscat Stock Exchange main index slipped by 66 points to close at 5,544 last week, led by profit-taking from
Read More
The capital Muscat is a top destination for 79% of EMEA travelers planning holidays in 2026, per Marriott Bonvoy's report.
Read More
Muscat's Port Sultan Qaboos welcomed the cruise ship Mein Schiff 4, with 2,386 tourists, marking the 2025-2026 cruise season launch.
Read More